Logo image of NNNN

ANBIO BIOTECHNOLOGY LTD (NNNN) Stock Overview

USA - NASDAQ:NNNN - KYG0367B1059 - Common Stock

29.61 USD
+0.15 (+0.51%)
Last: 10/8/2025, 11:32:46 AM

NNNN Key Statistics, Chart & Performance

Key Statistics
52 Week HighN/A
52 Week LowN/A
Market Cap1.30B
Shares43.89M
Float41.79M
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)0.04
PE740.25
Fwd PEN/A
Earnings (Next)N/A N/A
IPO02-19 2025-02-19
Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryBiotechnology


NNNN short term performance overview.The bars show the price performance of NNNN in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 100 200 300

NNNN long term performance overview.The bars show the price performance of NNNN in the last 1, 2 and 3 years. 1 year 2 years 3 years

The current stock price of NNNN is 29.61 USD. In the past month the price decreased by -35.91%.

ANBIO BIOTECHNOLOGY LTD / NNNN Daily stock chart

NNNN Latest News, Press Relases and Analysis

NNNN Competitors/Peers

The largest stocks on the US markets in the "Biotechnology" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
ABBV ABBVIE INC 21.79 407.69B
AMGN AMGEN INC 13.59 159.52B
GILD GILEAD SCIENCES INC 15.1 145.06B
VRTX VERTEX PHARMACEUTICALS INC 24.54 106.60B
REGN REGENERON PHARMACEUTICALS 12.81 61.97B
ALNY ALNYLAM PHARMACEUTICALS INC N/A 60.00B
ARGX ARGENX SE - ADR 86.22 48.92B
ONC BEONE MEDICINES LTD-ADR 5.64 38.40B
INSM INSMED INC N/A 34.39B
BNTX BIONTECH SE-ADR N/A 25.82B
NTRA NATERA INC N/A 23.68B
BIIB BIOGEN INC 9.45 22.17B

About NNNN

Company Profile

NNNN logo image Anbio Biotechnology is a medical device company. The company is headquartered in Frankfurt, Hessen and currently employs 27 full-time employees. The company went IPO on 2025-02-19. The firm is engaged in the development of medical technology and the provision of in vitro diagnostics (IVD) products. Its products offer solutions for over the counter (OTC) use, point-of-care (POCT) settings, and laboratory applications, ensuring that both healthcare providers and patients have access to reliable and efficient diagnostic tools in any setting. Its IVD products detect a wide range of biomarkers across critical medical fields, including infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Some of its IVD platforms: Chemiluminescence Immunoassay (ChLIA), Lateral Flow Immunoassay (LFIA), Fluorescent Immunoassay (FIA), Polymerase Chain Reaction (PCR) and Loop-mediated Isothermal Amplification (LAMP).

Company Info

ANBIO BIOTECHNOLOGY LTD

Friedrich-Ebert-Anlage 49

Frankfurt HESSEN DE

Employees: 27

NNNN Company Website

Phone: 4916096247281

ANBIO BIOTECHNOLOGY LTD / NNNN FAQ

What is the stock price of ANBIO BIOTECHNOLOGY LTD today?

The current stock price of NNNN is 29.61 USD. The price increased by 0.51% in the last trading session.


What is the ticker symbol for ANBIO BIOTECHNOLOGY LTD stock?

The exchange symbol of ANBIO BIOTECHNOLOGY LTD is NNNN and it is listed on the Nasdaq exchange.


On which exchange is NNNN stock listed?

NNNN stock is listed on the Nasdaq exchange.


What is ANBIO BIOTECHNOLOGY LTD worth?

ANBIO BIOTECHNOLOGY LTD (NNNN) has a market capitalization of 1.30B USD. This makes NNNN a Small Cap stock.


How many employees does ANBIO BIOTECHNOLOGY LTD have?

ANBIO BIOTECHNOLOGY LTD (NNNN) currently has 27 employees.


What are the support and resistance levels for ANBIO BIOTECHNOLOGY LTD (NNNN) stock?

ANBIO BIOTECHNOLOGY LTD (NNNN) has a support level at 25.94 and a resistance level at 34.13. Check the full technical report for a detailed analysis of NNNN support and resistance levels.


Should I buy ANBIO BIOTECHNOLOGY LTD (NNNN) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does ANBIO BIOTECHNOLOGY LTD (NNNN) stock pay dividends?

NNNN does not pay a dividend.


What is the Price/Earnings (PE) ratio of ANBIO BIOTECHNOLOGY LTD (NNNN)?

The PE ratio for ANBIO BIOTECHNOLOGY LTD (NNNN) is 740.25. This is based on the reported non-GAAP earnings per share of 0.04 and the current share price of 29.61 USD. Check the full fundamental report for a full analysis of the valuation metrics for NNNN.


What is the Short Interest ratio of ANBIO BIOTECHNOLOGY LTD (NNNN) stock?

The outstanding short interest for ANBIO BIOTECHNOLOGY LTD (NNNN) is 0.39% of its float. Check the ownership tab for more information on the NNNN short interest.


NNNN Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

NNNN Fundamental Analysis

ChartMill assigns a fundamental rating of 6 / 10 to NNNN. NNNN gets an excellent profitability rating and is at the same time showing great financial health properties.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

NNNN Financial Highlights

Over the last trailing twelve months NNNN reported a non-GAAP Earnings per Share(EPS) of 0.04. The EPS increased by 57.95% compared to the year before.


Industry RankSector Rank
PM (TTM) 46.57%
ROA 30.88%
ROE 31.77%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%6.37%
Sales Q2Q%21.95%
EPS 1Y (TTM)57.95%
Revenue 1Y (TTM)43.63%

NNNN Forecast & Estimates


Analysts
AnalystsN/A
Price TargetN/A
EPS Next YN/A
Revenue Next YearN/A

NNNN Ownership

Ownership
Inst Owners4.85%
Ins OwnersN/A
Short Float %0.39%
Short Ratio2.13